Literature DB >> 15720441

Antithetical effects of hemicellulase-treated Agaricus blazei on the maturation of murine bone-marrow-derived dendritic cells.

Masaki Kawamura1, Hirotake Kasai, Limin He, Xuewen Deng, Atsuya Yamashita, Hiroshi Terunuma, Isao Horiuchi, Fuminori Tanabe, Masahiko Ito.   

Abstract

We report the effects of hemicellulase-treated Agaricus blazei (ABH) on the maturation of bone-marrow-derived dendritic cells (BMDCs). ABH activated immature BMDCs, inducing up-regulation of surface molecules, such as CD40, CD80 and major histocompatibility complex class I antigens, as well as inducing allogeneic T-cell proliferation and T helper type 1 cell development. However, unlike lipopolysaccharide (LPS), ABH did not stimulate the BMDCs to produce proinflammatory cytokines, such as interleukin-12 (IL-12) p40, tumour necrosis factor-alpha, or IL-1beta. In addition, ABH suppressed LPS-induced DC responses. Pretreatment of DCs with ABH markedly reduced the levels of LPS-induced cytokine secretion, while only slightly decreasing up-regulation of the surface molecules involved in maturation. ABH also had a significant impact on peptidoglycan-induced or CpG oligodeoxynucleotide-induced IL-12p40 production in DCs. The inhibition of LPS-induced responses was not associated with a cytotoxic effect of ABH nor with an anti-inflammatory effect of IL-10. However, ABH decreased NF-kappaB-induced reporter gene expression in LPS-stimulated J774.1 cells. Interestingly, DCs preincubated with ABH and then stimulated with LPS augmented T helper type 1 responses in culture with allogeneic T cells as compared to LPS-stimulated but non-ABH-pretreated DCs. These observations suggest that ABH regulates DC-mediated responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15720441      PMCID: PMC1782089          DOI: 10.1111/j.1365-2567.2004.02106.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  65 in total

Review 1.  Recognition of microbial infection by Toll-like receptors.

Authors:  Elizabeth Kopp; Ruslan Medzhitov
Journal:  Curr Opin Immunol       Date:  2003-08       Impact factor: 7.486

Review 2.  Dendritic cells and fungi.

Authors:  Eva Buentke; Annika Scheynius
Journal:  APMIS       Date:  2003 Jul-Aug       Impact factor: 3.205

Review 3.  Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases.

Authors:  Lisa G Criscione; E William St Clair
Journal:  Curr Opin Rheumatol       Date:  2002-05       Impact factor: 5.006

4.  CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2.

Authors:  Elke Scandella; Ying Men; Daniel F Legler; Silke Gillessen; Ladislav Prikler; Burkhard Ludewig; Marcus Groettrup
Journal:  Blood       Date:  2003-10-30       Impact factor: 22.113

5.  Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells.

Authors:  Masahide Yamada; Kenji Oritani; Tsuneyasu Kaisho; Jun Ishikawa; Hitoshi Yoshida; Isao Takahashi; Shinichirou Kawamoto; Naoko Ishida; Hidetoshi Ujiie; Hiroaki Masaie; Marina Botto; Yoshiaki Tomiyama; Yuji Matsuzawa
Journal:  Eur J Immunol       Date:  2004-01       Impact factor: 5.532

6.  Effects of crude extracts of Agaricus blazei on DNA damage and on rat liver carcinogenesis induced by diethylnitrosamine.

Authors:  Luís Fernando Barbisan; Clarissa Scolastici; Maristela Miyamoto; Daisy Maria Favero Salvadori; Lúcia Regina Ribeiro; Augusto Ferreira da Eira; João Lauro Viana de Camargo
Journal:  Genet Mol Res       Date:  2003-09-30

Review 7.  Toll-like receptors and innate antifungal responses.

Authors:  Alexander Roeder; Carsten J Kirschning; Rudolf A Rupec; Martin Schaller; Hans Christian Korting
Journal:  Trends Microbiol       Date:  2004-01       Impact factor: 17.079

8.  Oral administration of Agaricus blazei (H1 strain) inhibited tumor growth in a sarcoma 180 inoculation model.

Authors:  Yun-Lyul Lee; Heui-Jin Kim; Mi-Sook Lee; Ji-Min Kim; Jin-Soo Han; Euk-Ki Hong; Myung-Sang Kwon; Min-Jae Lee
Journal:  Exp Anim       Date:  2003-10

9.  Coimmunization of Agaricus blazei Murill extract with hepatitis B virus core protein through DNA vaccine enhances cellular and humoral immune responses.

Authors:  L Chen; H J Shao; Y B Su
Journal:  Int Immunopharmacol       Date:  2004-03       Impact factor: 4.932

10.  Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells.

Authors:  Evros Vassiliou; Huie Jing; Doina Ganea
Journal:  Cell Immunol       Date:  2003-06       Impact factor: 4.868

View more
  3 in total

1.  Pro-inflammatory effects of the mushroom Agaricus blazei and its consequences on atherosclerosis development.

Authors:  Juliana L Gonçalves; Eric H Roma; Ana Cristina Gomes-Santos; Edenil C Aguilar; Daniel Cisalpino; Luciana R Fernandes; Angélica T Vieira; Dirce R Oliveira; Valbert N Cardoso; Mauro M Teixeira; Jacqueline I Alvarez-Leite
Journal:  Eur J Nutr       Date:  2011-11-16       Impact factor: 5.614

2.  The Medicinal Mushroom Agaricus blazei Murrill: Review of Literature and Pharmaco-Toxicological Problems.

Authors:  F Firenzuoli; L Gori; G Lombardo
Journal:  Evid Based Complement Alternat Med       Date:  2008-03       Impact factor: 2.629

3.  Delayed Cell Cycle Progression and Apoptosis Induced by Hemicellulase-Treated Agaricus blazei.

Authors:  Masaki Kawamura; Hirotake Kasai
Journal:  Evid Based Complement Alternat Med       Date:  2006-09-11       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.